The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

By Puyaan Singh (Reuters) - The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Senator John Fetterman (D-PA) revealed he’s using a weight loss drug and is now asking the Trump Administration to make it easier for others to use it too. In a New York Times op-ed ...

Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...